Literature DB >> 33722955

Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis.

Jennifer L Beaumont1, Elizabeth S Davis1, Jeffrey R Curtis1, David Cella1, Huifeng Yun1.   

Abstract

OBJECTIVE: We estimated meaningful change thresholds (MCTs) for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference in rheumatoid arthritis (RA).
METHODS: The responsiveness of several patient-reported outcomes (PROs) was assessed among 521 patients with RA in the Arthritis, Rheumatism, and Aging Medical Information Systems (ARAMIS) cohort. PROMIS Fatigue (7-item) and Pain Interference (6-item) short form instruments were administered at baseline, 6 months, and 12 months. Self-reported retrospective changes over the previous 6 months (a lot better/ worse, a little better/worse, stayed the same) were obtained at 6 and 12 months' follow-up. We estimated MCTs using the mean change in PROMIS scores for patients who rated their change "a little better" or "a little worse."
RESULTS: Baseline fatigue and pain interference scores were near normal (median 54 and 56, respectively). At 6 months, 7.9% of patients reported their fatigue was a little better compared to baseline (mean change [SD]: -2.6 [4.8]) and 22.8% a little worse (1.7 [5.6]). Pain was a little better for 11.5% of patients (-1.9 [6.1]) and a little worse for 24.2% of patients (0.6 [5.7]). At 12 months, results were similar. Thus, the MCT range was 1-2 points for both fatigue and pain interference. Correlations between change scores and retrospective ratings were low (0.13-0.29), indicating possible underestimation of MCT.
CONCLUSION: The group-level MCT for PROMIS Fatigue and Pain Interference is roughly 2-3 points and corresponds to a small effect size, which is consistent with earlier work demonstrating an MCT of 2 points for PROMIS Physical Functioning.

Entities:  

Year:  2021        PMID: 33722955     DOI: 10.3899/jrheum.200990

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.

Authors:  Ana-Maria Orbai; Laura C Coates; Atul Deodhar; Philip S Helliwell; Christopher T Ritchlin; Evan Leibowitz; Alexa P Kollmeier; Elizabeth C Hsia; Xie L Xu; Shihong Sheng; Yusang Jiang; Yan Liu; Chenglong Han
Journal:  Patient       Date:  2022-06-30       Impact factor: 3.481

2.  Heart Disease Self-management for African American Older Adults: Outcomes of an Adapted Evidence-Based Intervention.

Authors:  Mary R Janevic; Jessica E Ramsay; Kristi L Allgood; Aida Domazet; Shaun Cardozo; Cathleen M Connell
Journal:  Innov Aging       Date:  2022-08-19

3.  Changes in cardiorespiratory function and fatigue following 12 weeks of exercise training in women with systemic lupus erythematosus: a pilot study.

Authors:  Sarfaraz Hasni; Li Rebekah Feng; Marquis Chapman; Sarthak Gupta; Anam Ahmad; Adam Munday; Mir Ali Mazhar; Xiaobai Li; Shajia Lu; Wanxia Li Tsai; Massimo Gadina; Michael Davis; Jun Chu; Zerai Manna; Shuichiro Nakabo; Mariana J Kaplan; Leorey Saligan; Randall Keyser; Leighton Chan; Lisa M K Chin
Journal:  Lupus Sci Med       Date:  2022-10

Review 4.  Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures.

Authors:  Caroline B Terwee; John Devin Peipert; Robert Chapman; Jin-Shei Lai; Berend Terluin; David Cella; Philip Griffith; Lidwine B Mokkink
Journal:  Qual Life Res       Date:  2021-07-10       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.